Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

John Henretta

Surgery Asheville, NC Medical Doctor

NPI 1033135868 CMS profile 92540

222 Asheland Ave, Asheville, NC 28801

Open in the dashboard

General payments

$9,873

159 records reported · program years 2019–2025

Research payments

$9,750

Paid to them · 5 records reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$167,752 paid to institutions, not to them · program years 2019–2025

Through program year 2025, John Henretta of Asheville, NC is reported in the CMS Open Payments database as having received $9,873 across 159 general payments and $9,750 in research payments paid to them. Separately, studies naming them as principal investigator received $167,752 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 90th percentile of Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

9 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,048 14
2024 General $1,315 30
2023 General $1,430 26
2022 General $1,065 22
2021 General $1,210 16
2020 General $839 14
2020 Research $5,750 3
2019 General $2,966 37
2019 Research $4,000 2

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • John Henretta
  • Surgery median
  • Middle half of Surgery
  • National median

In program year 2025, general payments to John Henretta were reported at $1,048. Among 17,702 Surgery profiles paid that year, the median was $280 and the middle half received between $91 and $1,259.

Show as a table
Year John Henretta Surgery median Middle half National median
2019 $2,966 $253 $82–$1,521 $163
2020 $839 $131 $40–$706 $114
2021 $1,210 $168 $50–$904 $132
2022 $1,065 $224 $76–$1,218 $149
2023 $1,430 $253 $82–$1,255 $160
2024 $1,315 $279 $90–$1,381 $164
2025 $1,048 $280 $91–$1,259 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Medtronic, Inc. $2,965 56 payments
  2. Silk Road Medical, Inc. $1,809 16 payments
  3. Medtronic Vascular, Inc. $1,251 19 payments
  4. W. L. Gore & Associates, Inc. $980 18 payments
  5. Bolton Medical Inc $829 14 payments
  6. Shockwave Medical, Inc $300 2 payments
  7. Endologix, Inc. $212 3 payments
  8. Stryker Corporation $208 3 payments
  9. Boston Scientific Corporation $206 3 payments
  10. Cook Medical LLC $203 3 payments
  11. Other $909 22 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $8,807 154 payments
  2. Travel and Lodging $1,066 5 payments
Products named General payments · program years 2019–2025
  1. ENDURANT IIS $2,349 45 payments
  2. ENROUTE 0.014 Guidewire $1,405 9 payments
  3. ENROUTE Transcarotid Stent System $1,405 9 payments
  4. ENROUTE Transcarotid Neuroprotection System Carotid Artery Disease $1,405 9 payments
  5. ENHANCE Transcarotid Peripheral Access Kit $1,405 9 payments
  6. Endurant Aortic Stent Grafts $1,129 18 payments
  7. TREO ABDOMINAL STENT-GRAFT SYSTEM $427 7 payments
  8. ENROUTE Transcarotid Stent $404 7 payments
  9. ENROUTE Transcarotid Neuroprotection System Cardiology/Vascular Diseases $404 7 payments
  10. Endurant Aortic Stent Grafts $372 7 payments
  11. Other $4,464 83 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Philips Electronics North America Corporation $9,750 5 payments

Prescribing to Medicare patients

Part D · data year 2024 · 3 drugs

Part D claims

50

Median for Vascular Surgery: 122

Drug cost

$557

Median for Vascular Surgery: $14,135

Branded share of claims

66%

Median for Vascular Surgery: 71%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Cilostazol Generic 17 $341
Clopidogrel Clopidogrel Bisulfate Brand 22 $124
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 11 $92

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 3,087 Part D prescribers listed as Vascular Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 104 billing codes

Paid by Medicare

$140,502

Medicare's payments for the services billed

Medicare patients

611

Average age 76

Services billed

1,255

272 women, 339 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Ischemic heart disease 51%
Chronic kidney disease 48%
Arthritis 47%
Diabetes 46%
COPD 35%
Heart failure 33%
Depression 30%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

164 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Surgery in North Carolina

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record